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Introduction
Colorectal cancer (CRC) is the second highest cause of death 
by cancer in the Western world, after bronchus and lung, 
and followed by breast, pancreas and prostate. Colorectal 
surgery or coloproctology separated from general surgery 
in the 1990s, later than many other subspecialties. Audit 
studies at this time showed that results improved under 
the management of specialist CRC surgeons, rather than 
generalists. Uncompromising conclusions were drawn from 
the study data. These demonstrated that “some general 
surgeons perform less-than-optimal CRC surgery and some 
are less competent technically than their colleagues”.1
While the breadth and sophistication of techniques for 
benign disease began to increase, there was also a flurry 
of advances in the management of CRC, both from a 
surgical and an oncological perspective. When former USA 
president Ronald Reagan contracted colon cancer in 1985, 
colonoscopic screening gained importance in that country. 
The rest of the Western world gradually followed. Screening 
using colonoscopy, as well as stool testing, was widely 
accepted as a cost-efficient method with high sensitivity. 
In the last 15 years, major advances in CRC management 
have included:
•	 Total mesorectal resection (TME). 
•	 Magnetic resonance imaging (MRI), computed 
tomography (CT) and endorectal ultrasound (ERUS) in 
CRC staging. 
•	 Preoperative (neoadjuvant) radiochemotherapy.
•	 Stenting of obstructed colons (still controversial).
•	 Laparoscopic resection.
•	 Local excision with transanal microscopic techniques 
(TEM/TEO).
•	 Multidisciplinary team assessment.
•	 Decline of indications for mechanical bowel preparation.
Total mesorectal excision 
In the early 1980s, Bill Heald, an English surgeon, 
demonstrated that the use of TME reduced local recurrence 
of CRC from 15-30% to less than 5%.2 This is a demanding 
procedure of 3-5 hours and requires skill, patience, 
exceptional assistants, considerable strength and stamina. 
It is also difficult to teach and learn. Heald showed that 
metastatic lymph nodes might lie in the mesorectum 
below the level of the cancer. Thus, the rectum needs to 
be excised with its mesorectal envelope which contains 
its regional lymphatics (Figure 1 a and b). This mandated 
the need for a perfect anatomical resection that would 
inevitably compromise blood supply to the residual rectal 
stump and increase the risk of anastomotic leak. Another 
challenge was to reduce the rate of permanent stoma 
formation by developing sphincter-saving techniques that 
require ultra-low resections and colo-anal anastomoses. 
These anastomoses are created on the pelvic floor, often 
out of view of the surgical team and utilise a variety of 
stapling devices that are challenging to use and which 
require familiarity and practice (Figures 2 a and b). In 
addition, TME needs to preserve flimsy, vulnerable 
structures, such as the pelvic nerves that control genito-
urinary organs and pelvic floor function (Figure 3). The use 
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of sharp dissection under vision, rather than blunt finger 
dissection, has led to the more frequent achievement of 
the three ideals of rectal cancer surgery: complete cancer 
resection, preservation of the nerves and a low anastomotic 
leak rate. The abdominoperineal resection rate, where the 
anus is sacrificed and the patient has a permanent stoma, 
has also declined. In a well-serviced patient population, 
TME requires experienced, properly trained colorectal 
resectionists.
Magnetic resonance imaging, computed 
tomography and endorectal ultrasound in 
colorectal cancer staging
MRI provides optimal images when organs are unaffected 
by movement or respiration. The rectum is one of these 
and contrasts well with the fatty tissue of the mesorectum 
(Figure 4). This facilitates good radiological assessment of 
tumour penetration and affected nodes. Patients should 
also undergo an abdominal and thoracic CT scan to assess 
distant spread. In South Africa, MRI remains considerably 
underutilised by surgeons in their assessment of CRC. The 
resultant images are of a far better quality than those that 
derive from a pelvic CT scan. Also, with practise, they are 
straightforward to analyse. Like orthopaedic surgeons, 
experienced rectal surgeons are able to interpret the images 
with more clinicopathological insight than radiologists 
who have little understanding of these aspects of CRC. 
MRI allows the clinician to decide when preoperative 
downstaging radiotherapy is appropriate and has been 
shown to be more accurate than digital examination, even 
when carried out by experienced colorectal surgeons. 
Positron emission tomography (PET) scanning has not 
proved to be of much value in preoperative staging for this 
disease and is rarely used.
ERUS is difficult to learn and harder to master. But in 
competent hands, it provides the best images of the layers 
Figure 1a: Complete rectal excision with intact mesorectum Figure 2a: Abdominal view of a mid-rectal staple line
Figure 1b: The lower border of the cancer is seen 2 cm above 
the distal rectal resection margin, which is encased in its fatty 
mesorectum Figure 2b: Endoscopic view of healed stapled rectal anastomosis
Figure 3: Intact pelvic sympathetic nerves after rectal excision
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of the rectal wall, thus allowing accurate staging of T0-T2 
lesions (Figure 5). Some early lesions may be suitable for 
local excision. Thus, ERUS has its major application in this 
important patient subgroup whose cancers require difficult 
therapeutic decisions. 
Local excision
The excision of early-stage rectal cancer via the anus 
is attractive, especially in patients with significant co-
morbidity. Traditionally, this has been a very challenging 
procedure because of limited access through the anal canal 
and difficulty with bleeding and diathermy smoke. The 
tumour is removed piecemeal by using lighted retractors and 
a diathermy needlepoint (Figure 6). This is slow and tedious. 
A sucker is in constant use for both blood and smoke. No 
attempt is made to close the raw area. The patient is given 
a rectal catheter and is placed on antibiotics for five days.
These difficulties have been overcome by the introduction of 
transanal endoscopic microsurgery (TEM or TEO) (Figure 7). 
This uses a 4-cm diameter, sealed operating proctoscope 
through which a laparoscopic telescope and instruments 
can be passed, allowing controlled and accurate excision 
with excellent vision and almost no bleeding (Figure 8 and 
9). Tumours as high up as 15 cm, and occupying three 
quarters of the rectal circumference, can be resected with 
little risk of morbidity. The obtained specimen will not have 
been traumatised and can be presented to the pathologist 
in one piece with minimal diathermy artifact, orientated and 
pinned on a corkboard. It has been introduced into South 
Africa recently. Our own initial series of 40 excisions has 
demonstrated these benefits.3
Preoperative radiotherapy 
Preoperative radiotherapy entered mainstream rectal cancer 
management approximately 10 years ago for selected 
tumours. Regrettably, in South Africa it remains rarely used 
by general surgeons who tend to proceed straight to surgery 
Figure 4: A magnetic resonance imaging sagittal view of low rectal 
cancer
Figure 5: Image generated by endorectal ultrasound. It demonstrates 
a large noninvasive adenoma
Figure 6: A fractured, disorientated specimen after a difficult transanal 
local excision
Figure 7: Transanal endoscopic microsurgery proctoscope with a 
5-mm lens that connects to the monitor
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and then only refer patients to oncologists for adjuvant 
therapies on receipt of an unfavourable histology report. 
Preoperative radiotherapy plays two roles. First it can 
be used to shrink a large cancer (T4) that is unlikely to 
be resectable with clear margins, or it can be used to 
downstage a T3 (the most common stage) lesion, when the 
nodal status is uncertain. This has been shown to reduce 
local recurrence, the most feared complication of rectal 
cancer because of the inability to excise it. This results in 
debilitating symptoms which are very difficult to palliate. 
Usually, T1 and T2 lesions do not require preoperative 
radiotherapy.
Patients receive between 40 and 50 Gy in two Gy doses, 
five days a week for 4-5 weeks, including radiosensitising 
chemotherapy during the first week. Surgery is planned 
at least eight weeks after completion of radiotherapy. It is 
becoming increasingly clear that there is an advantage in 
delaying even longer, probably up to 12 weeks.4 Thus, the 
patient only undergoes surgery 4-5 months after starting 
therapy, a strategy that requires a significant shift away 
from traditional rectal cancer surgical management by 
non-specialists.
Radiotherapy can be given in 5 Gy fractions over five days 
(the so-called 5 x 5 protocol) to selected patients with T3 
rectal cancer, but surgery must take place within five days 
of completion, before the acute phase response has begun.
The rationale in applying radiotherapy before surgery is 
based on the following:
•	 It should be applied to well vascularised and oxygenated 
tissue so that healthy pelvic tissue is better able to 
recover from its effects than it would do after surgical 
trauma.
•	 The implantation of viable cancer cells during surgery will 
be minimised.
•	 The small bowel is mobile and above the peritoneal 
reflection, and not fixed in the pelvis (as is the case after 
surgery), while its exposure to damaging irradiation will 
be minimised.
•	 The neo-rectum, which is derived from the descending 
colon, will not have been exposed to radiotherapy and 
will be healthy, pliant and free of any radiotherapy injury.
•	 Usually, the preoperative patient is well and able to 
tolerate the demands of radiotherapy treatment. 
However, if surgical complications ensue because of 
an anastomotic leak, for example, patients will become 
ineligible for postoperative radiotherapy because of the 
long delay before they are able to tolerate the treatment. 
A simple way to conceptualise the role of preoperative 
radiotherapy is that oncologically it sterilises the tissue at 
the resection margins, while downstaging the cancer itself. 
There is a complete oncological response to preoperative 
radiotherapy in approximately 15% of patients, resulting 
in a resection specimen with no residual tumour. Whether 
or not it is safe to simply observe patients whose tumours 
appear to be complete responders, as assessed by scans 
and biopsy, is the subject of current research.
In summary, irradiation is more dose-effective when given 
preoperatively, rather than postoperatively.
Stenting of obstructed colons 
Colonic obstruction is a fatal condition potentially. It carries 
mortality rates 15-22% with emergency surgery. Patients 
are often in poor condition, elderly and dehydrated and a 
colostomy is the usual outcome; and is often permanent.
Endoscopic, self-expanding metal colonic stent placement, 
to relieve left-sided obstructing colon cancers, is used 
to avoid emergency surgery and may be carried out as 
definitive palliation or as a “bridge to surgery”. In the latter 
setting, the stent decompresses the obstructed colon 
(Figure 10), allowing patient resuscitation and optimisation 
for surgery at a later stage (Figure 11). However, 80% of 
colonic obstruction aetiology is malignancy, so that many 
patients who have been decompressed are then found 
to have metastases or co-morbidity that contraindicates 
Figure 8: Surgeon’s view of operating field seen on monitor Figure 9: Rectal wall defect after tumour excision. It may be closed 
with endoscopic suturing
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surgery. In this setting, the stent assumes a palliative role, 
as the patient requires no further surgical intervention and 
colostomy is avoided. 
The stent is deployed over a guide wire via the colonoscope, 
using fluorescence guidance. It requires training and skill, but 
a large series from Groote Schuur Hospital has illustrated its 
facility in a local setting.5 The concern of tumour perforation 
by the stent remains a debate, but it is a valuable alternative 
if the expertise exists.
Laparoscopic colorectal cancer surgery 
Laparoscopic colorectal cancer surgery has potential 
advantages, including less pain, a shorter hospital stay, a 
quicker return of gastrointestinal function, better cosmesis, 
less adhesions and fewer wound problems, such as an 
incisional hernia. However, these must be weighed against 
greatly increased theatre time and equipment costs. The 
use thereof also features a very long learning curve, even 
for surgeons who are experienced in other laparoscopic 
operations. An example is laparoscopic total colectomy 
which substitutes a full length abdominal incision for a short 
suprapubic one, but requires more time, cost and a long 
learning curve (Figures 12-14).
An advantage of laparoscopic surgery is that abdominal 
operations in high body mass index subjects are easier 
laparoscopically than via laparotomy, for example, 
cholecystectomy, fundoplication, appendicectomy and 
adrenalectomy. However, this does not apply in colorectal 
surgery, where laparoscopy is significantly more difficult 
than open surgery in overweight patients, and also has the 
difficulties of fragile mesenteric fat and vasculature, the 
challenge of retracting of the omentum and small bowel 
out of the operation field and a high variability in organ 
length and flexure anatomy. Also, the construction of 
intra-abdominal anastomoses requires expensive stapling 
devices.
Data from large centres show only modest short-term 
benefits, and stress the importance of expert laparoscopic 
colorectal cancer surgeons to achieve these results. 
Modest outcome data from large multicentre trials, for 
example conversion rates above 20%, are often criticised 
by laparoscopic enthusiasts. The participating surgeons are 
disparaged for not being sufficiently skilled, even when they 
are based in specialist colorectal units where the surgery 
and equipment is of a higher standard than that found 
among general surgeons in South Africa. 
Laparoscopic colorectal cancer surgery must demonstrate 
real clinical benefits, such as improved negative radial 
margin rates, adequate lymph node yields and the sparing 
of pelvic nerves with improved sexual and pelvic floor 
function (Figure 3). It should not be implemented solely for 
the marginal benefits of a smaller incision, fewer hernias, 
magnified views of the pelvis or minimal tumour handling.
Surgeons in developing nations who wish to introduce 
laparoscopic colorectal cancer surgery must ensure that 
delivery of cancer surgery of good quality is the primary 
goal. The need for high-quality, properly resourced 
laparoscopic training facilities must be recognised. Instead 
of laparoscopy, the priority should be to ensure that patients 
with rectal cancer are managed by colorectal surgeons, 
rather than general surgeons who are untrained in TME and 
in the use of neoadjuvant therapies. Once achieved, logical 
progression to laparoscopic colorectal cancer surgery can 
take place. Existing laparoscopic colorectal cancer surgery, 
as practised by general surgeons, is only likely to discredit 
this type of surgery, increase costs and foster standards 
that encourage mediocrity, rather than excellence. Good 
open surgeons should continue with good open surgery.6
Bowel preparation 
The need for bowel preparation in colorectal surgery has 
long been questioned. It causes dehydration and starves 
the patient in advance of major surgical trauma. Electrolyte 
Figure 10: Abdominal X-ray of a decompressed bowel after stent 
placement 
Figure 11: Resected specimen containing a stent that was used as a 
“bridge to surgery”
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and fluid shifts have been proven to be effective. The colon 
is seldom completely clean and the liquid residual stool 
is left to challenge the new anastomosis. A large body of 
evidence has shown that avoidance of mechanical bowel 
preparation does not lead to an increase in complications, 
such as anastomotic leak and reduced bowel preparation- 
associated morbidity.7 Patients prefer it too. The data are 
unequivocal for colon surgery. Some reservations remain 
with regard to low rectal anastomoses.
Multidisciplinary team assessment 
This review has illustrated the need for numerous disciplines 
in CRC management. The multidisciplinary team approach 
recognises this and usually takes the form of a regular 
meeting at which patients are assessed by a colorectal 
surgeon, radiation oncologist, radiologist, pathologist, 
stomaltherapist or colorectal nurse specialist. The weekly 
CRC meetings at Groote Schuur Hospital are one of 
the oldest in the world, dating back to the 1970s. This is 
harder to achieve in private practice, but the surgeon needs 
to ensure that he has access to his own team of CRC-
orientated specialists in order to provide consistent opinion, 
reliable communication and a team approach. 
Conclusion
Colorectal cancer is the most common cancer killer 
after lung cancer. Its management has been significantly 
improved by recent advances, but many of these have still 
not been incorporated into South African surgical practice. 
There are less than 10 registered colorectal surgeons in the 
country. Currently, a CRC patient deserves consideration 
for MRI scanning, preoperative radiotherapy, TME, stenting 
when there is acute obstruction, laparoscopy, or local 
excision with TEO in selected situations, avoidance of bowel 
preparation and evaluation via a multidisciplinary team 
approach. There have been considerable improvements 
in stomal therapy and fistulous wound management as a 
result of the introduction of colorectal nurse specialists. 
These colleagues also provide an essential preoperative 
counselling service. Two other areas of real advance have 
been the growing acceptance of routine colonoscopic 
screening and the development of routine metasectomy 
surgery, particularly in the liver, and also in the lung. While 
only a small number of patients are suitable for this surgery, 
it has led to more structured follow-up programmes that 
have sought to identify resectable secondaries. 
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Figure 12: Specimen delivery through a suprapubic incision after 
laparoscopic total colectomy for megacolon
Figure 14: The postoperative abdomen
Figure 13: Handsewn ileorectal anastomosis and wound retractor 
